Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07236437 · ClinicalTrials.gov registry record · NA
Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care
A NA study, sponsored by Scott A. Irwin, MD, PhD.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07236437: Clinical Trial NA study, sponsored by Scott A. Irwin, MD, PhD.
NCT07236437 is a NA study that has not yet begun recruiting, run by Scott A. Irwin, MD, PhD. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07236437, a NA study, has not yet begun recruiting, sponsored by Scott A. Irwin, MD, PhD.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The goal of this study is to evaluate the efficacy and cost-effectiveness of the Living Well Program, a digital therapeutic application with telecoaching support, in breast cancer patients with moderate-to-severe anxiety. The main question the study aims to answer is: does digital cognitive-behavioral therapy-based interventions decrease the overall healthcare costs of patients with stage II to IV breast cancer? The study has one group of participants who will use the Living Well app and telecoaching support. This group will be compared to retroactively matched controls. Over 3 months, patients will complete 21 mental health modules and 5 telecoaching sessions. In the following 3 months, they will complete any outstanding telecoaching sessions and modules while still being monitored, even if they finished all modules and sessions in the first 3 months. The 6 months after that will be the follow-up phase. They will still have access to the Living Well app and may continue to use it, and they will complete the same assessment questionnaires as baseline to identify any changes in their overall mental health.
Interventions
- DEVICE Living Well Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-11-15 |
| Est. Completion | 2027-11-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07236437
The ClinicalTrials.gov registry entry for NCT07236437 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Scott A. Irwin, MD, PhD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Living Well Program is the first listed.
NCT07236437 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07236437 about?
NCT07236437 is a clinical study titled "Living Well Program: Impact on Healthcare Costs and Clinical Outcomes in Breast Cancer Care". The goal of this study is to evaluate the efficacy and cost-effectiveness of the Living Well Program, a digital therapeutic application with telecoaching support, in breast cancer patients with moderate-to-severe anxiety. The main question the study aims to answer is: does digital cognitive-behavior...
What is the current status of trial NCT07236437?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2025-11-15. Estimated completion is 2027-11-15.
What interventions are being tested in trial NCT07236437?
The interventions under investigation include: Living Well Program (DEVICE).
Who is sponsoring clinical trial NCT07236437?
This trial is sponsored by Scott A. Irwin, MD, PhD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.